Bank of New York Mellon’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.11M | Buy |
|
|||||
|
2025
Q2 | $2.55M | Buy |
|
|||||
|
2025
Q1 | $2.44M | Buy |
|
|||||
|
2024
Q4 | $3.6M | Buy |
|
|||||
|
2024
Q3 | $3.94M | Sell |
|
|||||
|
2024
Q2 | $4.36M | Buy |
|
|||||
|
2024
Q1 | $2.34M | Sell |
|
|||||
|
2023
Q4 | $1.79M | Buy |
|
|||||
|
2023
Q3 | $1.34M | Buy |
|
|||||
|
2023
Q2 | $1.65M | Buy |
|
|||||
|
2023
Q1 | $1.41M | Sell |
|
|||||
|
2022
Q4 | $1.76M | Buy |
|
|||||
|
2022
Q3 | $2.07M | Buy |
|
|||||
|
2022
Q2 | $1.72M | Buy |
|
|||||
|
2022
Q1 | $1.46M | Buy |
|
|||||
|
2021
Q4 | $3.01M | Buy |
|
|||||
|
2021
Q3 | $2.94M | Buy |
|
|||||
|
2021
Q2 | $2.07M | Buy |
|
|||||
|
2021
Q1 | $2.07M | Buy |
|
|||||
|
2020
Q4 | $1.46M | Buy |
|
|||||
|
2020
Q3 | $974K | Buy |
|